[Cutaneous leukocytoclastic vasculitis in a patient with pulmonary tuberculosis].
I
I
Ilias
K
K
Papachristou
G
G
Vassilikos
N
N
Filippou
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D017445:Skin Diseases, Vascular / Q000382:microbiology*; D014397:Tuberculosis, Pulmonary / Q000150:complications*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000382:microbiology*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Vasculite leucocytoclasique cutanée chez un patient atteint de tuberculose pulmonaire.